The Drugs and Cosmetics Act, 1940 and Rules made there under provide the mechanism for ensuring the safety, quality and efficacy of imported as well as domestically manufactured drugs. The import of drugs into the country is regulated by the Central Drugs Standard Control Organization (CDSCO), while the manufacture, sale and distribution of drugs are regulated by the State Licensing Authorities (SLAs) under the said Act and Rules.
As per media reports, regulatory actions have been taken by the United States Food and Drugs Administration (USFDA) against a few Indian pharmaceutical companies in cases of non-conformance to USFDA requirements.
Every country has its own system for evaluation of continued marketing of drugs. The marketing of a drug in a country, which is banned in another country, is decided based on the evaluation of disease pattern, reported side effects and overall safety and efficacy profile of the drug and availability of safer alternatives, etc. Certain drugs like Pioglitazone, Nimesulide and Analginare banned in certain countries but are allowed to be marketed in India with some restrictions based on their evaluation in the country.